William R. Markesbery
Impact in
- Biological Psychiatry top 0.05%
- Physiology top 0.01%
- Alzheimer's disease research and treatments
Papers in
- Physiology 180
- Alzheimer's disease research and treatments 161
-
- Dementia and Cognitive Impairment Research 59
- Co-authors
- Mark A. Lovell (62 shared papers)David Allan Butterfield (49 shared papers)Jeffrey N. Keller (29 shared papers)Richard J. Kryscio (25 shared papers)Michael Y. Aksenov (15 shared papers)David A. Snowdon (23 shared papers)Frederick A. Schmitt (28 shared papers)Charles David Smith (25 shared papers)
- Journals
- Neurobiology of Aging (34 papers)Journal of Neuropathology & Experimental Neurology (32 papers)Neurology (31 papers)Annals of Neurology (22 papers)Journal of Neurochemistry (19 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
William R. Markesbery
408 papers receiving 52.2k citations
William R. Markesbery's Hit Papers
Peers
Comparison fields: 5 of 198
- Biological Psychiatry 2.3k
- Physiology 22.1k
- Neurology 6.7k
- Psychiatry and Mental health 5.5k
- Biochemistry 2.3k
Countries citing papers authored by William R. Markesbery
This map shows the geographic impact of William R. Markesbery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Markesbery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Markesbery more than expected).
Fields of papers citing papers by William R. Markesbery
This network shows the impact of papers produced by William R. Markesbery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Markesbery. The network helps show where William R. Markesbery may publish in the future.
Co-authors
The 25 scholars most cited alongside William R. Markesbery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 418 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain Hit paper breakdown → | 1990 | 2533 |
| 2 | Oxidative Stress Hypothesis in Alzheimer's Disease Hit paper breakdown → | 1997 | 2109 |
| 3 | Copper, iron and zinc in Alzheimer's disease senile plaques Hit paper breakdown → | 1998 | 1892 |
| 4 | Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. Hit paper breakdown → | 1998 | 1565 |
| 5 | Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Hit paper breakdown → | 1991 | 1133 |
| 6 | Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses Hit paper breakdown → | 2004 | 867 |
| 7 | 2000 | 729 | |
| 8 | Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. Hit paper breakdown → | 1997 | 721 |
| 9 | A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide Hit paper breakdown → | 1997 | 703 |
| 10 | 1999 | 702 | |
| 11 | Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation Hit paper breakdown → | 1995 | 682 |
| 12 | Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease Hit paper breakdown → | 1998 | 626 |
| 13 | 2001 | 579 | |
| 14 | 1995 | 577 | |
| 15 | 1995 | 558 | |
| 16 | Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease Hit paper breakdown → | 2009 | 547 |
| 17 | 2008 | 533 | |
| 18 | 2002 | 526 | |
| 19 | 2002 | 519 | |
| 20 | 1996 | 482 |
About William R. Markesbery
William R. Markesbery is a scholar working on Physiology, Psychiatry and Mental health, Neurology, Cellular and Molecular Neuroscience and Nutrition and Dietetics, having authored 418 papers that have together received 54.8k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (161 papers), Dementia and Cognitive Impairment Research (59 papers), Mitochondrial Function and Pathology (38 papers), Trace Elements in Health (37 papers), Heavy Metal Exposure and Toxicity (29 papers), Cholinesterase and Neurodegenerative Diseases (23 papers), Neuroscience and Neuropharmacology Research (21 papers) and Antioxidant Activity and Oxidative Stress (19 papers). The work is most often cited by research in Biological Psychiatry (2.3k citations), Physiology (22.1k citations), Neurology (6.7k citations), Psychiatry and Mental health (5.5k citations) and Biochemistry (2.3k citations). William R. Markesbery has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Mark A. Lovell, David Allan Butterfield, Jeffrey N. Keller, Richard J. Kryscio, Michael Y. Aksenov, David A. Snowdon, Frederick A. Schmitt, Charles David Smith, John M. Carney and W. D. Ehmann. Their work appears in journals such as Neurobiology of Aging, Journal of Neuropathology & Experimental Neurology, Neurology, Annals of Neurology and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.